Skip to main content
Clinical Trials/RBR-63czrx
RBR-63czrx
Not yet recruiting
Phase 2

Effect of prebiotic and simbiotic supplementation on lipidic and glycemic profile, inflammatory markers and symptoms of depression and anxiety in individuals with diabetes mellitus type 1 and 2: randomized clinical trial, placebo-controlled and triple blind

niversidade Federal de Santa Catarina0 sitesJanuary 19, 2018

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Diabetes mellitus, Type 1 diabetes, type 2 diabetes, depression, anxiety, inflamation
Sponsor
niversidade Federal de Santa Catarina
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 19, 2018
End Date
TBD
Last Updated
2 years ago
Study Type
Intervention

Investigators

Sponsor
niversidade Federal de Santa Catarina

Eligibility Criteria

Inclusion Criteria

  • Volunteers who are diagnosed with type 1 or type 2 diabetes mellitus; both genders; age above 19 years.

Exclusion Criteria

  • Individuals with previous gastrointestinal diseases; previous gastrointestinal surgeries; intolerances or food allergies; use of anti\-inflammatory drugs or antibiotics up to three months prior to study or during study; regular use of laxatives; use of opioid narcotic analgesics; use of appetite suppressants; current or previous use up to one month of probiotic symbiotic prebiotics or products enriched with these ingredients; presenting intolerance to prebiotics or probiotics or symbiotics; pregnant or lactating women; following a diet for weight loss or gain in the last three months; current follow\-up of unusual diets; alcohol dependence; illicit drugs and smokers.

Outcomes

Primary Outcomes

Not specified

Similar Trials